You are here
General articles on Gastrointestinal Cancer
This section of the Advances in Gastrointestinal Cancer Resource Centre is where you will find cutting edge data on gastrointestinal cancers in the form of peer-reviewed original articles and review articles and the latest guidelines, all independently selected and several commented upon by members of the Editorial Board. Many of the articles are freely available for downloading.
Focusing initially on gastric cancer, these pages will provide new content each month to help you stay abreast of recent scientific developments in this area.
Since 1975, stomach cancer has dropped from first position to fifth in the list of most common cancers in the world, after lung, breast, colorectal, and prostate cancers.1 In most of the world, however, few cases of stomach cancer are detected at an early stage, and 5-year survival rates range from less than 20% in developing countries to 54% in Japan, where a national screening programme facilitates earlier detection and treatment.2
To stay abreast of the most recent developments in the epidemiology and treatment of gastrointestinal cancers, please subscribe to our eAlert to ensure you are informed of all new content as it is published on this platform.
1. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from: globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 6 April 2016.
2. American Cancer Society. Global Cancer Facts & Figures. 3rd edition. Atlanta: American Cancer Society; 2015.
Chan BA, Jang RW, Wong RK, Swallow CJ, Darling GE, Elimova E.Oncology (Williston Park) 2016 Jul;30(7):635-45. Review.
Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N.J Natl Cancer Inst 2016 Jul 14;108(9)
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
Harada K, Baba Y, Shigaki H, Ishimoto T, Miyake K, Kosumi K, et al.BMC Cancer 2016 Jul 7;16:400.
Low Preoperative Prognostic Nutritional Index Predicts Poor Survival Post-gastrectomy in Elderly Patients with Gastric Cancer
Sakurai K, Tamura T, Toyokawa T, Amano R, Kubo N, Tanaka H, et al.Ann Surg Oncol. 2016 May 20. [Epub ahead of print]
Uhlik MT, Liu J, Falcon BL, Iyer S, Stewart J, Celikkaya H, et al.Cancer Res. 2016 May 1;76(9):2573-86.
Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, et al.Ann Surg Oncol. 2016 Jun;23(6):1971-9.
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
Al-Batran SE, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka SAnn Oncol 2016 Jan 7. pii: mdv625. [Epub ahead of print]
Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data
Janowitz T, Thuss-Patience P, Marshall A, Kang JH, Connell C, Cook N, et al.Br J Cancer 2016 Feb 16;114(4):381-7
Kang BW, Seo AN, Yoon S, Bae HI, Jeon SW, Kwon OK, etal.Ann Oncol. 2016 Mar;27(3):494-501